Study title: Bioavailability and efficacy of Konakion MM Ro 01-6722/130, 1.5mg vitamin K1 i.m. versus 3.0mg vitamin K1 oral in healthy newborn breast-fed babies
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Digestive System Diseases [C06] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: PHYTOMENADION | |||||
| ATC code: B02BA01 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: B-115'046 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | Y | - | - | - | |